OptimizeRx

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell OptimizeRx and other ETFs, options, and stocks.

About OPRX

OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. 

CEO
Stephen L. Silvestro
CEOStephen L. Silvestro
Employees
129
Employees129
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
1985
Founded1985
Employees
129
Employees129

OPRX Key Statistics

Market cap
127.41M
Market cap127.41M
Price-Earnings ratio
24.95
Price-Earnings ratio24.95
Dividend yield
Dividend yield
Average volume
582.88K
Average volume582.88K
High today
$7.00
High today$7.00
Low today
$6.50
Low today$6.50
Open price
$6.60
Open price$6.60
Volume
527.12K
Volume527.12K
52 Week high
$22.25
52 Week high$22.25
52 Week low
$3.99
52 Week low$3.99

Stock Snapshot

With a market cap of 127.41M, OptimizeRx(OPRX) trades at $7.00. The stock has a price-to-earnings ratio of 24.95.

During the trading session on 2026-03-10, OptimizeRx(OPRX) shares reached a daily high of $7.00 and a low of $6.50. At a current price of $7.00, the stock is +7.7% higher than the low and still 0.0% under the high.

Trading volume for OptimizeRx(OPRX) stock has reached 527.12K, versus its average volume of 582.88K.

Over the past 52 weeks, OptimizeRx(OPRX) stock has traded between a high of $22.25 and a low of $3.99.

Over the past 52 weeks, OptimizeRx(OPRX) stock has traded between a high of $22.25 and a low of $3.99.

OPRX News

TipRanks 3d
Optimizerx Earnings Call: Profits Strong, Growth Cautious

Optimizerx Corporation ((OPRX)) has held its Q4 earnings call. Read on for the main highlights of the call. Claim 70% Off TipRanks Premium Unlock hedge fund-lev...

Seeking Alpha 4d
OptimizeRx signals $109M-$114M revenue target for 2026 as market shifts drive cautious outlook

Earnings Call Insights OptimizeRx signals $109M-$114M revenue target for 2026 as market shifts drive cautious outlook Mar. 05, 2026 6:46 PM ET OptimizeRx Corpor...

OptimizeRx signals $109M-$114M revenue target for 2026 as market shifts drive cautious outlook
Nasdaq 4d
OptimizeRx Q4 2025 Earnings Call Transcript

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX AD...

OptimizeRx Q4 2025 Earnings Call Transcript

Analyst ratings

86%

of 7 ratings
Buy
85.7%
Hold
14.3%
Sell
0%

More OPRX News

TipRanks 4d
OptimizeRx Authorizes $10 Million Share Repurchase Program

OptimizeRx ( (OPRX) ) has issued an announcement. On March 2, 2026, OptimizeRx amended its financing agreement to extend the maturity date by two years to Octo...

TipRanks 4d
OptimizeRx reports Q4 EPS 51c, consensus 22c

Reports Q4 revenue $32.24M, consensus $30.91M. Stephen Silvestro, OptimizeRx (OPRX) CEO commented, “We delivered a strong fourth quarter, exceeding both consens...

People also own

Based on the portfolios of people who own OPRX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.